Status:

RECRUITING

I-Score: Intensive Stroke Cycling for Optimal Recovery and Economic Value

Lead Sponsor:

The Cleveland Clinic

Conditions:

Stroke

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Traditional rehabilitation approaches are time and personnel intensive and costly, and leave \~75% of stroke survivors with residual disability. We propose a clinical trial to determine effects of for...

Detailed Description

Traditional rehabilitation approaches following stroke involve 1:1 motor learning-based training to facilitate recovery of upper extremity (UE) and lower extremity (LE) function. These time- and perso...

Eligibility Criteria

Inclusion

  • Sixty-six individuals with chronic stroke able to provide informed consent who meet the following criteria for inclusion will be recruited from the Cleveland Clinic:
  • 3-9 months following single ischemic or hemorrhagic stroke confirmed with neuroimaging (ie: first-time stroke)
  • Fugl-Meyer motor score 19-55 in the involved UE
  • Fugl-Meyer score \<34 in the involved LE demonstrating residual hemiparesis
  • Ambulatory ≥ 20 meters with no more than contact guard assistance
  • 18-85 years of age
  • Exclusion criteria include:
  • hospitalization for myocardial infarction, heart failure or heart surgery within 3 months
  • cardiac arrhythmia
  • hypertrophic cardiomyopathy
  • history of multiple strokes
  • actively undergoing physical or occupational therapy or enrolled in another interventional study
  • severe aortic stenosis
  • untreated deep vein thrombosis or pulmonary embolus
  • unstable angina
  • uncontrolled hypertension
  • implanted pacemaker or defibrillator
  • dyspnea at rest
  • clinically significant neurologic condition/diagnosis other than stroke
  • recent history of elicit drug or alcohol misuse or significant mental health illness
  • significant contractures
  • anti-spasticity injection within 3 months of enrollment
  • skull hardware (e.g. screws/plates) or prior craniotomies that could shunt current flow altering EEG measures
  • other contraindication to exercise or EEGs

Exclusion

    Key Trial Info

    Start Date :

    September 18 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 1 2029

    Estimated Enrollment :

    66 Patients enrolled

    Trial Details

    Trial ID

    NCT06585943

    Start Date

    September 18 2024

    End Date

    April 1 2029

    Last Update

    October 16 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cleveland Clinic

    Cleveland, Ohio, United States, 44195